Feasible management of median arcuate ligament syndrome in orthotopic liver transplantation recipients

Table 1 Characteristics and prognoses of patients with median arcuate ligament syndrome who received orthotopic liver transplantation

Characteristics and prognoses	1	2	3	4	5	6	7	8
Age, donor/recipient	55/52	54/53	67/66	45/48	62/63	52/62	56/38	50/63
Sex, donor/recipient	F/F	M/F	M/M	F/M	M/M	M/F	M/M	M/F
BMI, donor/recipient	20/19	22/22	22/23	21/19	23/20	26/21	22/20	25/21
Donor cause of death	CVA	CVA	Trauma	CVA	Trauma	CVA	CVA	Trauma
The primary disease	PBC	AIH	AIH	Viral	Viral	Viral	Viral	HCC
MALS type	B	B	B	C	A	B	A	A
Cold ischemic time in min	608	348	461	582	586	510	550	458
Warm ischemic time in s	19	15	41	29	12	26	15	16
Intraoperative blood loss in mL	1800	1500	2850	3000	7000	300	1000	2000
Intra-operative red blood cell transfusions in U	4	20	10.5	22	27	9	8	16.5
Intra-operative fresh frozen plasma transfusions in mL	1000	2350	1200	950	3600	960	420	960
Operation time in min	485	580	526	538	632	556	560	452
Intraoperative hepatic arterial blood flow rate in cm/s	NA	80	90	50	60	65	50	53
Hepatic arterial blood flow rate on discharge in cm/s	80	85	102	64	65	70	60	68
Hospital stay in d	17	28	39	18	21	17	17	15

AIH: Autoimmune hepatitis; BMI: Body mass index; CVA: Cerebrovascular accident; F: Female; HCC: Hepatocellular carcinoma; M: Male; NA: Not available; PBC: Primary biliary cirrhosis.